NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘pharmaceutical’

8 July 2014

Great Point backs temp-controlled package business Softbox through growth recap

Softbox Healthcare-focused investment firm Great Point Partners has made a growth recapitalisation of UK temperature-controlled packaging business Softbox.

3 June 2014

Venture capital-backed stem cell science developer DefiniGEN closes £2.28m Series A

news_plant_cell_lrg Stem cell life sciences business DefiniGEN has closed its £2.28m Series A financing round led by Cambridge Enterprise and 24 Haymarket.

20 May 2014

Wellcome Trust, Gates Foundation back UK antibody developer Kymab

UK-based biopharmaceutical business Kymab has picked up $40m through a Series B financing round from the Bill & Melinda Gates Foundation and existing backer the Wellcome Trust.

12 May 2014

Tailwind set for VersaPharm exit as Akorn agrees $440m buyout

pharma_lrg Tailwind Capital-backed drug maker VersaPharm is set to be bought by Akorn in a $440m all-cash deal.

28 March 2014

Biopharma developer scPharmaceuticals seals $16m Series A VC round

Biopharmaceutical company scPharmaceuticals has closed a $16m Series A venture financing round co-led by life sciences investors 5AM Ventures and Lundbeckfond Ventures.

20 March 2014

J-Star hires Yuki Kashiyama as operating principle

Japanese flag pole Japanese private equity firm J-Star has appointed Yuki Kashiyama as an operating principle.

7 March 2014

Montagu Private Equity buys dietary supplement developer Arkopharma

European private equity firm Montagu is to acquire pharmaceutical laboratory Arkopharma from the company’s founding family.

6 March 2014

Cough and cold, ADHD drug delivery developer Neos seals $15.5m funding

A venture capital backed drug delivery developer currently targeting behavioural disorder ADHD has picked up another $15.5m of financing.

24 February 2014

CCMP seals $915m exit for Medpace with sale to Cinven

US private equity firm CCMP is to exit contract research organisation Medpace, with its sale to Cinven for $915m.

12 February 2014

VC backed Cadence Pharmaceuticals sells for $1.3bn

NYSE-listed pharmaceuticals company Mallinckrodt has agreed to acquire VC-backed Cadence Pharmaceuticals for $1.3bn.

Page 1 of 1812345...10...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014